Nephrology and Chronic Kidney Disease
Clinical research at Klinikum Nuernberg is centered on stage 3 chronic kidney disease, with attention to preserving kidney function and addressing progression in patients with moderate renal impairment.
- Renal function preservation
- Chronic kidney disease management
- Kidney disease progression
The sponsor’s trial activity includes interest in therapies that support renal glucose handling and maintain beneficial effects linked to SGLT2 inhibitor-based treatment.
Metabolic Renal Therapy
Its research focus also extends to treatment strategies that connect glucose metabolism with kidney protection, reflecting interest in therapies that influence renal metabolic pathways.
- Renal glucose excretion
- Glucose-lowering kidney therapies
- Metabolic support in kidney disease
Work in this area relates to maintaining the kidney-related benefits of dapagliflozin and evaluating adjunctive approaches such as balcinrenone in renal disease.
